Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.60 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.60 |
| ▸ | TST | Q16762 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | PRKCA | P17252 | 9/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL874725 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL15364 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL16950234 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL936066 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL875292 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL444603 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL1503121 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL875399 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL22730055 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL875356 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9293 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6372755-B1 | — | — | None | — | — | US | claimed |
| CN-122005334-A | Polyglycerol-10 oleate nanometer inclusion with particle size smaller than 20nm and natural sources, and preparation method, application and composition thereof | 上海林清轩化妆品集团股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260115155-A1 | STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN | CHORDA PHARMA INC (US) | 2026-04-30 | — | — | US | claimed |
| EP-4717276-A2 | OPHTHALMIC COMPOSITIONS COMPRISING LEVODOPA, AN ANTIOXIDANT AND AN AQUEOUS CARRIER | University of Canberra (AU) | 2026-04-01 | — | — | EP | claimed |
| EP-3346842-B1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | NOVONESIS PLANT BIOSOLUTIONS AS (DK) | 2026-03-25 | — | — | EP | claimed |
| US-12575581-B2 | Barrier coating compositions, wash compositions, and other compositions for perishables and methods, systems, kits and coated items relating thereto | COMESTAAG LLC (US) | 2026-03-17 | — | — | US | claimed |
| EP-4687859-A2 | DESMOPRESSIN ORAL COMPOSITIONS | TULEX PHARMACEUTICALS, INC. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20250352532-A1 | REDUCED NITROSAMINE FORMATION IN PHARMACEUTICAL COMPOSITIONS COMPRISING METHYLPHENIDATE | MEDICE ARZNEIMITTEL PUETTER GMBH & CO KG (DE) | 2025-11-20 | — | — | US | claimed |
| EP-4649943-A1 | REDUCED NITROSAMINE FORMATION IN PHARMACEUTICAL COMPOSITIONS COMPRISING METHYLPHENIDATE | Medice Arzneimittel Pütter GmbH & Co. KG (DE) | 2025-11-19 | — | — | EP | claimed |
| EP-3442516-B1 | OPHTHALMIC COMPOSITIONS COMPRISING LEVODOPA, AN ANTIOXIDANT AND AN AQUEOUS CARRIER | UNIV CANBERRA (AU) | 2025-11-12 | — | — | EP | claimed |
| US-5376361-A | Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage | N.V. PERRICONE LLC | 1994-12-27 | — | — | US | claimed |
| EP-0607642-A1 | Compositions for topical application to the skin for treatment and/or prevention of radiation-induced skin damage | PERRICONE, Nicholas V., Dr. (US) | 1994-07-27 | — | — | EP | claimed |
| EP-0353161-B1 | Antioxidant system based on a stabilized ascorbic ester | OREAL (FR) | 1994-07-20 | — | — | EP | claimed |
| CN-1076110-A | Percutaneous is given so that the patch of skin-whitening materials | PACIFIC CHEM CO LTD (KR) | 1993-09-15 | — | — | CN | claimed |
| US-5114716-A | Stabilization of cosmetics | SOCIETE ANONYME DITE: L'OREAL (FR) | 1992-05-19 | — | — | US | claimed |
| EP-0280606-B1 | ANTI-OXIDANT SYSTEM BASED ON A STABILIZED ASCORBYL ESTER CONTAINING AT LEAST A COMPLEXANT AND A THIOL, AND COMPOSITIONS CONTAINING THIS SYSTEM | L'OREAL (FR) | 1992-04-15 | — | — | EP | claimed |
| US-5023235-A | Cosmetics | L'OREAL (FR) | 1991-06-11 | — | — | US | claimed |
| EP-0090378-A1 | Isoprenylcarboxylic acid-containing composition for external use | Eisai Co., Ltd. (JP) | 1983-10-05 | — | — | EP | claimed |
| US-4357469-A | HYDROXYPROPYLMETHYL CELLULOSE, MIXTURES WITH ETHYL CELLULOSE OR SODIUM CARBOXYMETHYL CELLULOSE | FOREST LABORATORIES, INC. (US) | 1982-11-02 | — | — | US | claimed |
| US-4226849-A | CARRIER BASE HYDROXYPROPYLMETHYLCELLULOSE, ETHYL CELLULOSE | FOREST LABORATORIES INC. (US) | 1980-10-07 | — | — | US | claimed |